Pharmacological interactions of statins
- 28 May 2002
- journal article
- review article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 3 (1), 35-40
- https://doi.org/10.1016/s1567-5688(02)00002-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Intravenous diltiazem and CYP3A-mediated metabolismBritish Journal of Clinical Pharmacology, 2000
- Concomitant use of cytochrome P450 3A4 inhibitors and simvastatinThe American Journal of Cardiology, 1999
- Enhanced cholesterol reduction by simvastatin in diltiazem‐treated patientsBritish Journal of Clinical Pharmacology, 1999
- Drug Interactions of Lipid-Altering DrugsDrug Safety, 1998
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- EVALUATION OF FLUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS TAKING CYCLOSPORINE1Transplantation, 1996
- Pharmacology of competitive inhibitors of HMg-CoA reductasePharmacological Research, 1995
- Plasma Concentration Profiles of Simvastatin 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitory Activity in Kidney Transplant Recipients with and without CiclosporinNephron, 1993
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988